JAMES PATRICK HOFFMAN
Medical Practice in Blue Bell, PA
License number
Pennsylvania MD013073E
Category
Medicine
Type
Medical Physician and Surgeon
Address
Address
Blue Bell, PA 19422
Personal information
See more information about JAMES PATRICK HOFFMAN at radaris.comName
Address
Phone
499 E Penn St, Muncy, PA 17756
490 Colebrook Rd, Mount Joy, PA 17552
44 N Elmer Ave, Halifax, PA 17032
44 N Elmer Ave APT 4, Halifax, PA 17032
441 Livingston Rd, West Mifflin, PA 15122
Professional information
Prophylactic Docosahexaenoic Acid Therapy For Patients With Subclinical Inflammation
US Patent:
2004010, Jun 3, 2004
Filed:
Sep 29, 2003
Appl. No.:
10/672059
Inventors:
Linda Arterburn - Ellicott City MD, US
James Hoffman - Blue Bell PA, US
Harry Oken - Columbia MD, US
Mary Van Elswyk - Longmont CO, US
James Hoffman - Blue Bell PA, US
Harry Oken - Columbia MD, US
Mary Van Elswyk - Longmont CO, US
International Classification:
A61K031/60, A61K031/4743, A61K031/202
US Classification:
514/165000, 514/560000, 514/301000
Abstract:
This invention is directed to methods and compositions which impede the development and progression of diseases associated with subclinical inflammation. Subclinical inflammation is commonly associated with atherosclerotic cardiovascular disease, coronary disease or cerebrovascular disease. The methods and compositions of the invention are also particularly suited to providing therapy for subclinical inflammation in diabetic and prediabetic patients. Methods of the invention comprise administration of DHA alone and in combination with antiplatelet drugs.
Container Device For Separately Storing And Mixing Two Ingredients
US Patent:
4731053, Mar 15, 1988
Filed:
Dec 23, 1986
Appl. No.:
6/945749
Inventors:
James P. Hoffman - Blue Bell PA
Assignee:
Merck & Co., Inc. - Rahway NJ
International Classification:
A61M 3700
US Classification:
604 89
Abstract:
The present invention relates to a container device that is useful for separately storing two ingredients, typically a solid ingredient and a liquid ingredient, and subsequently mixing the two ingredients within the container device. The container device is especially useful for the storage of a solid ingredient that can be degraded during storage, by moisture, and a liquid ingredient wherein, when such ingredients are mixed, the mixture is stable for only a short period of time.
Prophylactic Docosahexaenoic Acid Therapy For Patients With Subclinical Inflammation
US Patent:
2009020, Aug 13, 2009
Filed:
Feb 3, 2009
Appl. No.:
12/364893
Inventors:
Linda Arterburn - Ellicott City MD, US
James Hoffman - Blue Bell PA, US
Harry Oken - Columbia MD, US
Mary Van Elswyk - Longmont CO, US
James Hoffman - Blue Bell PA, US
Harry Oken - Columbia MD, US
Mary Van Elswyk - Longmont CO, US
Assignee:
Martek Biosciences Corporation - Columbia MD
International Classification:
A61K 31/202, A61P 29/00, A61K 31/60, A61K 31/4365, A61P 3/00
US Classification:
514163, 514560, 514301
Abstract:
This invention is directed to methods and compositions which impede the development and progression of diseases associated with subclinical inflammation. Subclinical inflammation is commonly associated with atherosclerotic cardiovascular disease, coronary disease or cerebrovascular disease. The methods and compositions of the invention are also particularly suited to providing therapy for subclinical inflammation in diabetic and prediabetic patients. Methods of the invention comprise administration of DHA alone and in combination with antiplatelet drugs.
Glycemic Control For Prediabetes And/Or Diabetes Type Ii Using Docosahexaenoic Acid
US Patent:
2004009, May 13, 2004
Filed:
Sep 29, 2003
Appl. No.:
10/672077
Inventors:
Linda Arterburn - Ellicott City MD, US
Diane Benisek - Severna Park MD, US
James Hoffman - Blue Bell PA, US
Harry Oken - Columbia MD, US
Mary Van Elswyk - St. Longmont CO, US
Diane Benisek - Severna Park MD, US
James Hoffman - Blue Bell PA, US
Harry Oken - Columbia MD, US
Mary Van Elswyk - St. Longmont CO, US
International Classification:
A61K038/28, A61K031/426, A61K031/202, A61K031/175
US Classification:
514/560000, 514/003000, 514/365000, 514/592000
Abstract:
This invention is directed to methods of treating patients with metabolic syndrome, prediabetes and/or Type II diabetes mellitus by administering docosahexaenoic acid (DHA) alone or in combination with diabetes-related medications.
Prophylactic Docosahexaenoic Acid Therapy For Patients With Subclinical Inflammation
US Patent:
2006006, Mar 30, 2006
Filed:
Sep 12, 2005
Appl. No.:
11/223128
Inventors:
Linda Arterburn - Ellicott City MD, US
James Hoffman - Blue Bell PA, US
Harry Oken - Columbia MD, US
Mary Van Elswyk - Longmont CO, US
James Hoffman - Blue Bell PA, US
Harry Oken - Columbia MD, US
Mary Van Elswyk - Longmont CO, US
Assignee:
Martek Biosciences Corporation - Columbia MD
International Classification:
A61K 31/202
US Classification:
514560000
Abstract:
This invention is directed to methods and compositions which impede the development and progression of diseases associated with subclinical inflammation. Subclinical inflammation is commonly associated with atherosclerotic cardiovascular disease, coronary disease or cerebrovascular disease. The methods and compositions of the invention are also particularly suited to providing therapy for subclinical inflammation in diabetic and prediabetic patients. Methods of the invention comprise administration of DHA alone and in combination with antiplatelet drugs.